BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15352897)

  • 21. Review article: problematic proctitis and distal colitis.
    Gionchetti P; Rizzello F; Morselli C; Campieri M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():93-6. PubMed ID: 15352902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results.
    Lazzerini M; Martelossi S; Marchetti F; Scabar A; Bradaschia F; Ronfani L; Ventura A
    Aliment Pharmacol Ther; 2007 Feb; 25(4):419-27. PubMed ID: 17269997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
    Rutgeerts P
    Mediators Inflamm; 1998; 7(3):137-40. PubMed ID: 9705597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?
    De Cassan C; Fiorino G; Danese S
    Dig Dis; 2012; 30(4):368-75. PubMed ID: 22796798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New treatments in inflammatory bowel disease.
    Cole AT; Hawkey CJ
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):581-90. PubMed ID: 1591558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy of chronic inflammatory intestinal diseases].
    Raedler A; Reinecker C
    Immun Infekt; 1990 Aug; 18(4):121-6. PubMed ID: 2210794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of inflammatory bowel disease in adults.
    Katz JA
    J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease.
    Klotz U; Schwab M
    Adv Drug Deliv Rev; 2005 Jan; 57(2):267-79. PubMed ID: 15555742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():15-21. PubMed ID: 18307645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive therapy of inflammatory diseases of the large intestine].
    Rumiantsev VG; Rogozina VA; Osina VA
    Eksp Klin Gastroenterol; 2004; (6):89-98, 165. PubMed ID: 16259448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral locally active steroids in inflammatory bowel disease.
    Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
    J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the management of steroid dependency in ulcerative colitis.
    Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S
    Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of steroid-naive ulcerative colitis.
    Bossa F; Colombo E; Andriulli A; Annese V
    Expert Opin Pharmacother; 2009 Jun; 10(9):1449-60. PubMed ID: 19445560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
    Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.